Yamo Pharmaceuticals

0 followers

‌

Yamo Pharmaceuticals is a clinical-stage pharmaceutical company that develops L1-79, a novel therapy for Autism spectrum disorder.

Industries

Pharmaceutical, Biotechnology

Headquarters

New York, United States

Employees

1-10

Links

Org chart

Chuck Bramlage

Chief Executive Officer

Chuck Bramlage

Collapse

Eugene Prahin

Chief Financial Officer

Tracy Fischer

Senior Vice President – Regulatory Affairs & Quality

Uyen Nguyen

Vice President Of Clinical Research Operations

Brian Cahill

Chief Financial Officer

Teams

This company has no teams yet

Similar companies

AbbVie

181 followers

Incyte

15 followers

Recursion Pharmaceuticals

9 followers

Amgen

217 followers

Elanco

20 followers

Bristol-Myers Squibb

189 followers

Thermo Fisher Scientific

169 followers

Genentech

150 followers

Gilead Sciences

129 followers

Biogen

115 followers

Regeneron

96 followers

Explore companies